Large-Scale Drug Screening in Patient-Derived IDH(mut) Glioma Stem Cells Identifies Several Efficient Drugs among FDA-Approved Antineoplastic Agents

Lignende værker

• DDIS-22. DRUG SCREEN IN PATIENT-DERIVED IDHMUT GLIOMA STEM CELLS IDENTIFIES SEVERAL FDA-APPROVED ANTINEOPLASTIC AGENTS
  af: Dao Trong, Philip, et al.
  Udgivet: (2019)
• DDIS-34. HIGH-THROUGHPUT DRUG SCREENING OF FDA-APPROVED ANTINEOPLASTIC DRUGS FOR THE TREATMENT OF AGGRESSIVE MENINGIOMAS
  af: Jungwirth, Gerhard, et al.
  Udgivet: (2019)
• DDRE-30. HIGH-THROUGHPUT DRUG SCREENING OF FDA-APPROVED ANTINEOPLASTIC DRUGS FOR THE TREATMENT OF AGGRESSIVE MENINGIOMAS
  af: Jungwirth, Gerhard, et al.
  Udgivet: (2020)
• Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma
  af: Dao Trong, Philip, et al.
  Udgivet: (2018)
• EXTH-63. IN VITRO DRUG SCREENING BASED ON IN SILICO DATA IDENTIFIES NEW THERAPEUTIC AGENTS FOR AGGRESSIVE MENINGIOMA
  af: Jungwirth, Gerhard, et al.
  Udgivet: (2020)